BACKGROUND: Cockroach is an important allergen in inner-city asthma. The diagnosis and treatment of cockroach allergy has been impeded by the lack of standardized cockroach extracts. OBJECTIVE: We investigated the utility of a mediator release assay based on rat basophil leukemia (RBL) cells for comparing the potency of German cockroach extracts. METHODS: RBL cells (line 2H3) transfected with human FcepsilonRI were passively sensitized with sera from subjects with cockroach allergy and stimulated with serial dilutions of 3 commercial cockroach extracts (1:10 weight/volume). In addition, the in-house prepared extract was tested in separate experiments with pooled sera that produced optimal performance in the RBL assay. N-hexosaminidase release (NHR) was used as a marker of RBL cell degranulation and was examined in relation to the intradermal skin test (ID(50)EAL) and serum cockroach-specific and total IgE levels. RESULTS: The median cockroach-specific IgE concentration in 60 subjects was 0.72 kU(A)/L (interquartile range, 0.35-2.97 kU(A)/L); 19 sera (responders) produced a minimum 10% NHR to more than 1 extract. Responders had higher median cockroach-specific IgE (7.4 vs 1.0 kU(A)/L) and total IgE (429 vs 300 kU/L) levels than nonresponders. Ranking of extract potency was consistent between the mediator release assay and the ID(50)EAL. For the in-house prepared cockroach extract, the dose-response curves were shifted according to the concentration of the extract. NHR was reproducible between different experiments by using pooled sera. CONCLUSION: The mediator release assay measures biologic potency and correlates with the ID(50)EAL. It should be further evaluated to determine whether it could be used to replace intradermal skin test titration for assessing the potency of cockroach extract.
BACKGROUND: Cockroach is an important allergen in inner-city asthma. The diagnosis and treatment of cockroach allergy has been impeded by the lack of standardized cockroach extracts. OBJECTIVE: We investigated the utility of a mediator release assay based on rat basophil leukemia (RBL) cells for comparing the potency of German cockroach extracts. METHODS: RBL cells (line 2H3) transfected with humanFcepsilonRI were passively sensitized with sera from subjects with cockroach allergy and stimulated with serial dilutions of 3 commercial cockroach extracts (1:10 weight/volume). In addition, the in-house prepared extract was tested in separate experiments with pooled sera that produced optimal performance in the RBL assay. N-hexosaminidase release (NHR) was used as a marker of RBL cell degranulation and was examined in relation to the intradermal skin test (ID(50)EAL) and serum cockroach-specific and total IgE levels. RESULTS: The median cockroach-specific IgE concentration in 60 subjects was 0.72 kU(A)/L (interquartile range, 0.35-2.97 kU(A)/L); 19 sera (responders) produced a minimum 10% NHR to more than 1 extract. Responders had higher median cockroach-specific IgE (7.4 vs 1.0 kU(A)/L) and total IgE (429 vs 300 kU/L) levels than nonresponders. Ranking of extract potency was consistent between the mediator release assay and the ID(50)EAL. For the in-house prepared cockroach extract, the dose-response curves were shifted according to the concentration of the extract. NHR was reproducible between different experiments by using pooled sera. CONCLUSION: The mediator release assay measures biologic potency and correlates with the ID(50)EAL. It should be further evaluated to determine whether it could be used to replace intradermal skin test titration for assessing the potency of cockroach extract.
Authors: P J Gergen; K M Mortimer; P A Eggleston; D Rosenstreich; H Mitchell; D Ownby; M Kattan; D Baker; E C Wright; R Slavin; F Malveaux Journal: J Allergy Clin Immunol Date: 1999-03 Impact factor: 10.793
Authors: Shama M Satinover; Amanda J Reefer; Anna Pomes; Martin D Chapman; Thomas A E Platts-Mills; Judith A Woodfolk Journal: J Allergy Clin Immunol Date: 2005-04 Impact factor: 10.793
Authors: R van Ree; M D Chapman; F Ferreira; S Vieths; D Bryan; O Cromwell; M Villalba; S R Durham; W M Becker; M Aalbers; C André; D Barber; A Cistero Bahima; A Custovic; A Didierlaurent; C Dolman; J W Dorpema; G Di Felice; F Eberhardt; E Fernandez Caldas; M Fernandez Rivas; H Fiebig; M Focke; K Fötisch; G Gadermaier; R G Das; E Gonzalez Mancebo; M Himly; T Kinaciyan; A C Knulst; A M Kroon; U Lepp; F M Marco; A Mari; P Moingeon; R Monsalve; A Neubauer; S Notten; P Ooievaar-de Heer; G Pauli; C Pini; A Purohit; J Quiralte; S Rak; M Raulf-Heimsoth; M M San Miguel Moncin; B Simpson; A Tsay; L Vailes; M Wallner; B Weber Journal: Allergy Date: 2008-03 Impact factor: 13.146
Authors: Didier G Ebo; Margo M Hagendorens; Chris H Bridts; Annemie J Schuerwegh; Luc S De Clerck; Wim J Stevens Journal: Cytometry B Clin Cytom Date: 2005-03 Impact factor: 3.058
Authors: G William Palmer; Donald A Dibbern; A Wesley Burks; Gary A Bannon; S Allan Bock; Harry S Porterfield; Robert A McDermott; Stephen C Dreskin Journal: Clin Immunol Date: 2005-06 Impact factor: 3.969
Authors: P A Eggleston; D Rosenstreich; H Lynn; P Gergen; D Baker; M Kattan; K M Mortimer; H Mitchell; D Ownby; R Slavin; F Malveaux Journal: J Allergy Clin Immunol Date: 1998-10 Impact factor: 10.793
Authors: L Karla Arruda; Michelle C R Barbosa; Ana Beatriz R Santos; Adriana S Moreno; Martin D Chapman; Anna Pomés Journal: Curr Allergy Asthma Rep Date: 2014-04 Impact factor: 4.806
Authors: Ramon Bencharitiwong; Hanneke P M van der Kleij; Stef J Koppelman; Anna Nowak-Węgrzyn Journal: Allergy Asthma Proc Date: 2015 May-Jun Impact factor: 2.587
Authors: Jay Portnoy; Ginger L Chew; Wanda Phipatanakul; P Brock Williams; Carl Grimes; Kevin Kennedy; Elizabeth C Matsui; J David Miller; David Bernstein; Joann Blessing-Moore; Linda Cox; David Khan; David Lang; Richard Nicklas; John Oppenheimer; Christopher Randolph; Diane Schuller; Sheldon Spector; Stephen A Tilles; Dana Wallace; James Seltzer; James Sublett Journal: J Allergy Clin Immunol Date: 2013-08-09 Impact factor: 10.793